Activity of drug combinations against dormant mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2712-2715

  Filippini, Perla ^a   Iona, Elisabetta ^a   Piccaro, Giovanni ^a   Peyron, Pascale ^b,c   Neyrolles, Olivier ^b,c   Fattorini, Lanfranco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; METRONIDAZOLE; MOXIFLOXACIN; RIFAMPICIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CONTROLLED STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ADIPOCYTES; AMIKACIN; ANIMALS; ANTITUBERCULAR AGENTS; AZA COMPOUNDS; CAPREOMYCIN; COLONY COUNT, MICROBIAL; DRUG COMBINATIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; LATENT TUBERCULOSIS; METRONIDAZOLE; MICE; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; QUINOLINES; RIFAMPIN;

EID: 77952638904     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01736-09     Document Type: Article

References (14)

1. Barry, C. E., III, H. I. Boshoff, and C. S. Dowd. 2004. Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis. Curr. Pharm. Des. 10:3239-3262.
2. Barry, C. E., III, H. I. Boshoff, V. Dartois, T. Dick, S. Ehrt, J. Flynn, D. Schnappinger, R. J. Wilkinson, and D. Young. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7:845-855.
3. Cho, S. H., S. Warit, B. Wan, C. H. Hwang, G. F. Pauli, and S. G. Franzblau. 2007. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51:1380-1385.
4. Edwards, D. I. 1993. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:9-20.
5. Heifets, L., J. Simon, and V. Pham. 2005. Capreomycin is active against non-replicating M. tuberculosis. Ann. Clin. Microbiol. Antimicrob. 4:6.
6. Hu, Y. M, P. D. Butcher, K. Sole, D. A. Mitchison, and A. R. Coates. 1998. Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol. Lett. 158:139-145.
7. Hu, Y., J. A. Mangan, J. Dhillon, K. M. Sole, D. A. Mitchison, P. D. Butcher, and A. R. Coates. 2000. Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J. Bacteriol. 182:6358-6365.
8. Iona, E., F. Giannoni, M. Pardini, L. Brunori, G. Orefici, and L. Fattorini. 2007. Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51:1537-1540.
9. Kohanski, M. A., D. J. Dwyer, B. Hayete, C. A. Lawrence, and J. J. Collins. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810.
10. Neyrolles, O., R. Hernández-Pando, F. Pietri-Rouxel, P. Fornès, L. Tailleux, J. A. Barrios Payán, E. Pivert, Y. Bordat, D. Aguilar, M. C. Prévost, C. Petit, and B. Gicquel. 2006. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 1:e43.
11. Sacchettini, J. C., E. J. Rubin, and J. S. Freundlich. 2008. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat. Rev. Microbiol. 6:41-52.
12. Wayne, L. G., and H. A. Sramek. 1994. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:2054-2058.
13. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
14. Wayne, L. G. 2001. In vitro model of hypoxically induced nonreplicating persistence of Mycobacterium tuberculosis, p. 247-269. In T. Parish and N. Stoker (ed.), Methods in molecular medicine. Mycobacterium tuberculosis protocols. Humana Press, Totowa, NJ.